Drug Law Weekly

CV Therapeutics, Inc. - European marketing application for ranolazine is withdrawn

CV Therapeutics, Inc. - Heart disease drug maker reports option grants

Cambrex Corp. - Drug discovery tools maker reports 5.3% increase in sales

Catholic University of Chile - Immature Ucn antisense RNA is expressed naturally in the rat brain

Centre Hospitalier de l'Universite de Hautepierre, Strasbourg - Guidelines for Sertoli cell tumor of the testis in children needed

Chad Therapeutics, Inc. - Respiratory care device maker evaluating strategies for shareholder value

Charles University, Hradec Kralove - High-dose rate brachytherapy and external beam radiotherapy used to treat soft tissue sarcomas

Chiesi Farmaceutici S.p.A. - Novel antinociceptive agent CHF3381 inhibits capsaicin-induced pain in rats

Chinese Peoples' Liberation Army General Hospital - Human telomerase reverse transcriptase gene may be therapeutic in bladder cancer

Chiron Corp. - Contract inked to supply United States with pandemic influenza vaccine for stockpile

Chiron Vaccines - Reports advance knowledge in vaccines adjuvant research

Chosun University, Kwangju -  Lycium chinense root bark isolate has potential as antibiotic lead compound

City of Hope National Medical Center, Duarte - Metaplastic breast cancer and adenocarcinoma should have similar treatment plans

Clinical Trials - Study shows sargramostim therapy improves quality of life in Crohn disease

Collaborations - Partnership to jointly develop information therapy best practices

Cornell University, Ithaca - Stainless-steel surface topography influences microbicidal effect of pulsed light treatment

Cross Cancer Institute, Edmonton - BLP25 liposome vaccine may extend survival in non-small-cell lung cancer

DOR BioPharma, Inc. - Letter of intent executed for acquisition of Gastrotech Pharma

DOV Pharmaceutical, Inc. - New bicifadine data presented at scientific symposium

Decision Resources, Inc. - Report finds reformulated drugs will drive market for treatment of chronic pain

Dow Pharmaceutical Sciences - U.S. FDA approves NDA for Clobex Spray for moderate-to-severe plaque psoriasis

Dr. Daniel Den Hoed Cancer Center, Rotterdam - Chronic indwelling pleural catheter enables effective outpatient management

Dresden University of Technology - Radiation induced lung reactions during breast cancer therapy

Duke University Medical Center, Durham - Decoy agent fails to prevent bypass graft narrowing

Duquesne University, Pittsburgh - Studies describe new findings in drug development research

Dynavax Technologies Corp - U.S.-based phase I clinical trial of Heplisav, hepatitis B vaccine, in dialysis population begins

Dynavax Technologies Corp. - Tolamba maker announces third-quarter revenues of $0.4 million

Genentech, Inc. - U.S. FDA accepts supplemental BLA for Rituxan in rheumatoid arthritis

Medtox Scientific, Inc. - U.S. FDA grants clearance for new drugs-of-abuse point-of-collection test device

National Instruments - Sanmina-SCI selects modular instruments to build medical device test system

Nektar Therapeutics - U.S. FDA extends review period for Exubera by 3 months

Oscient Pharmaceuticals Corporation - Biopharma company reports $5.9M in revenue for third quarter

Spectranetics Corporation - CLiRpath product line receives U.S. FDA clearance for increasing lasing capability

Tufts University, Boston - Cardiovascular toxicity of performance-enhancing substances reviewed

U.S. Food & Drug Administration - FDA approval summary for temozolomide plus radiation for glioblastoma multiforme released

Universal Detection Technology - Provider of early-warning bio-threat monitoring devices joins defense group

University of California, San Francisco - Cost-effectiveness of screening blood for West Nile virus depends on virus prevalence

Washington University, St. Louis - Structural basis of West Nile virus neutralization by antibody elucidated